Polypharmacy and health-related quality of life/psychological distress among patients with chronic disease

Last updated on 20-8-2022 by Brecht Devleesschauwer

Public Access

Published

Peer reviewed scientific article

Engels

Samenvatting:

INTRODUCTION: To date, no study has investigated the impact of polypharmacy (use of ≥5 medications concurrently) on health-related quality of life (HRQOL) and psychological distress in a combined sample of chronic disease patients and patients with multimorbidity, using diverse HRQOL measures. This study aimed to explore the association between polypharmacy and HRQOL/psychological distress by using data from a cross-sectional study in Flanders (Belgium). METHODS: We analyzed cross-sectional survey data on 544 chronically ill patients recruited from June 2019 through June 2021. HRQOL was …

Associated health topics:

QR code

QR code for this page URL